Storia in 20 fonti

‘First time’: Drug giants’ cancer breakthrough

US drugmakers Merck and Moderna said Wednesday an experimental melanoma drug that delivers treatment tailored to a patient’s specific tumour prevented the cancer from returning in a large clinical trial.

Raccontata da

www1.folha.uol.com.br+8 altre

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

news.com.auStai leggendo15 h fa

‘First time’: Drug giants’ cancer breakthrough

originale

Timeline cronologica

mercoledì 19 agosto 2026·biopharmadive.com
Moderna and Merck cancer vaccine returns ‘landmark’ result in melanoma
At an interim data check, investigators of a key trial found the individualized mRNA treatment kept disease from returning and stopped its spread, sparking a surge in Moderna…
mercoledì 19 agosto 2026·en.mercopress.com
A personalized mRNA therapy passes a phase 3 melanoma trial for the first time
Pharmaceutical companies Merck, known as MSD outside the United States and Canada, and Moderna announced on Wednesday that their individualized neoantigen therapy, intismeran…

‘First time’: Drug giants’ cancer breakthrough

Confronto fonti

‘First time’: Drug giants’ cancer breakthrough

Timeline cronologica

Moderna and Merck cancer vaccine returns ‘landmark’ result in melanoma

A personalized mRNA therapy passes a phase 3 melanoma trial for the first time

'Breakthrough' mRNA cancer drug curbs melanoma in large trial

‘Breakthrough’ mRNA cancer drug curbs melanoma in large trial

A personalized mRNA therapy passes a phase 3 melanoma trial for the first time

mRNA’s second act: A bespoke cancer vaccine & what Merck-Moderna’s melanoma trial could mean for oncology

New Melanoma Vaccine Shows Promise In Fighting Cancer, Preventing Recurrence

mRNA melanoma vaccine-pembrolizumab combo shows survival gains in late-stage trial

Successo del farmaco antimelanoma, Moderna strappa a Wall Street

'Breakthrough' mRNA cancer drug curbs melanoma in large trial

Merck, Moderna say melanoma vaccine meets goals in large trial | CBC News

'Landmark moment' as vaccine stops cancer returning in striking trial

‘First time’: Drug giants’ cancer breakthrough

Melanoma, nuove speranze da vaccino sperimentale di Moderna e Merck: "Risultati promettenti" - Il Quotidiano del Sud

¿Cómo es la vacuna contra el cáncer de piel de Moderna y por qué ha sacudido los mercados?

Moderna's and Merck's personalized mRNA vaccine shows real promise against deadly skin cancer melanoma in late stage trial and sends stocks…

Nova vacina de mRNA pode impedir o retorno do câncer de pele

Melanoma, risultati positivi per il vaccino a mRna (la stessa tecnologia usata contro il Covid) personalizzato

Moderna and Merck shares soar on mRNA cancer vaccine

New Cancer Treatment Hope After mRNA Vaccine Success

Moderna y Merck anuncian el éxito de su vacuna contra el melanoma tras un ensayo con resultados prometedores

Moderna, Merck unveil mRNA-based cancer vaccine that cuts spread

‘Landmark’: New mRNA vaccine could prevent skin cancer from returning, companies say

Health Care Up After Moderna Breakthrough — Health Care Roundup

“Va a experimentar un gran auge”: el avance de dos laboratorios podría dar paso a una oleada de vacunas contra el cáncer